Sunday, Oct 17, 2021

Challenges and Opportunities for promoting pharmaceutical manufacturing in the Horn of Africa
in the context of COVID-19 pandemic

Conference Dates: October 20-21, 2021

Deadline for submissions: September 20, 2021, at 12.00am (East African Time)

Introduction

Regional pharmaceutical production in the IGAD region has received minimal support from the international community because most procurement systems encourage purchase of cheap imported medicines rather than investing in local production. Promotion of regional manufacture of essential medicines complements the continental agenda of the African Union, the Pharmaceutical Manufacturing Plan for Africa (PMPA) endorsed in 2007 by member states. The advent of COVID-19 augments the need to foster private sector stakeholder engagement within the pharmaceutical industry with the aim of strengthening the regional manufacture of essential lifesaving medicines. This conference will examine and discuss the challenges and opportunities in pharmaceutical manufacturing in the Horn of Africa in the context of COVID-19 pandemic. IGAD is convinced that making the case for collaborative investments in manufacturing will be cost effective if manufacturers can target the region rather than individual countries.

Guidelines for submission of Abstracts

This call invites ischolars and practitioners especially those from the continent of Africa and IGAD region with expertise in the subject matter to submit abstracts. Submitted abstracts should relate to the conference themes and follow the guideline below. Please ensure that you read and conform to the guidelines set out
below before submitting an abstract.

• Abstracts should be written in English or French and be 250-300 words excluding the abstract title, authors and their designations and INCLUDES up to 3 references (Harvard style) where necessary and appropriate.
https://libguides.mq.edu.au/referencing/Harvard;

Abstracts must use the following outline (with the exception of case reports):

  • Background
  • Aims, objective or purpose
  • Methods
  • Results
  • Conclusion

For case reports ONLY use the following section headings:

  • Background
  • Case Summary
  • Conclusion

• Interested authors should send a one-page CV/ bio, with latest publications and contact details (email address and phone numbers);

• Submissions should indicate the theme that the abstract falls under. Please select the most appropriate topic category that fits into your submission from this list below and indicate thematic number in your submission:

  1. Theme A1: Impact of coronavirus pandemic on manufacturing and supply chains in the Horn of Africa
  2. Theme A2: National and regional policies and trade-related challenges that affect manufacturing in the Horn of Africa
  3. Theme A3: Potential opportunities for manufacture of innovative medicines and vaccines in the Horn of Africa.
  4. Theme A4: Opportunities for pharmaceutical bulk pooled procurement in IGAD region

• Please send your abstracts and other documents to this e-mail address: This email address is being protected from spambots. You need JavaScript enabled to view it.

Important Dates

Deadline for submission of abstracts: August 31st, 2021

Notification of acceptance of abstracts: September 20th, 2021

Conference Dates: October 20-21, 2021

Information to note

 The decision of the reviewers and IGAD Secretariat on the acceptability of a submission is final.

 The reviewers and IGAD Secretariat reserve the right to accept or refuse an abstract and to choose a suitable session for the abstract.

 Declaration of Consent to Publication and Assignation of Copyright: By submitting an abstract the authors collectively accept that the submitted abstract constitutes my consent to publication (e.g. conference website, programs, other promotions, etc.). The Abstract Submitter also grants the IGAD Secretariat a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content. The IGAD Secretariat reserve the right to remove from any publication an abstract which does not comply with the above. The corresponding author is responsible for informing the other authors about the status of the abstract.

Partners: This Conference is organized by IGAD, United States Agency for International Development/Kenya and East Africa (USAID/KEA), United States Pharmacopeia Convention-Program on Quality of Medicines Plus (USP-PQM+), and the Medicines Technologies and Pharmaceutical Services (MTaPS) Program in cooperation with member states.

Organising committee: Please contact the conference secretariat if you have any queries regarding abstract submission. For any enquiries regarding the conference call for abstracts, please contact:

Hafsa Bashir Yussuf
IGAD Secretariat
IGAD Health and Social Development
Kenya Medical Training College - Karen Campus
P.O. Box 24921,
Nairobi – 00502, Kenya
T: + 254 710 241 313 or +254 724 065 344
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.


 

 

TB Care in the era of the COVID-19 pandemic, challenges and opportunities

Conference Dates: October 25th -28th, 2021

Deadline for submissions: September 10th, 2021, at 12.00am

Introduction

Cross-border population movement is a major social determinant of health and disease, including TB, multidrug resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) in the IGAD region. TB and TB/HIV co-infection are major public health problems in this region. Most of the TB/HIV infected are in sub-Saharan Africa with a coinfection rate of about 30% in 2016 . Two of the countries in the IGAD region (Ethiopia & Kenya) are among the WHO 30 high burden TB countries globally. Together with Somalia they are also in the WHO 30 high burden MDR-TB countries. Kenya, Uganda and Ethiopia are also in the high burden countries for TB - HIV. IGAD region has porous borders with two other neighboring high burden TB countries, Tanzania to the south and Democratic Republic of Congo to the west.

The region is affected by mixed migration flows originating from or transiting through the three main routes which are; The Northern Africa route (from sub-Saharan Africa

__________________________________________
1 WHO Global TB report 2017

to North Africa and Europe); the Gulf of Aden route (from the Horn of Africa to Yemen and beyond); and the Southern route (from the East and Horn of Africa to South Africa and beyond). The area also faces unique migration challenges due to the presence of nomadic and semi-nomadic pastoralists in all the IGAD countries. These regional dynamics are compounded by a general weakness of border and migration management which is characterized by porous borders, inadequately trained and poorly equipped staff, and insufficient regional technical cooperation.2

IGAD did an assessment in 2018 to gather information on the situation and services related to TB prevention and control at border health facilities in 24 border areas across the IGAD region. Among the findings are that the health facilities are far and wide apart, patients travel long distances, and diagnostic facilities for TB, are few, low proportion of staff positions filled, proportion of facilities providing TB services is low, most border health facilities do not receive regular TB trainings and supervision.

MDR-TB is a growing concern in the IGAD region and there have been efforts aimed at increased detection of MDR-TB cases but its treatment poses formidable challenges to national TB programs.

The global strategy to end TB aims to reach at least 90% of all people with TB, including key populations, and achieve at least 90% treatment success. The pillars include integrated patient centered care and prevention, Bold Policies and Supportive Systems, and the pillar of intensified research and innovation.

IGAD with support from USAID is holding a learning event and a scientific conference to bring together researchers and National Ministries of Health from the Member States to present their papers and experiences at the conference.

Guidelines for submission of Abstracts

This call invites scholars and practitioners especially those from the continent of Africa and IGAD region with expertise in the subject matter to submit abstracts. Submitted abstracts should relate to the conference themes and follow the guidelines below. Please ensure that you read and conform to the guidelines set out below before submitting an abstract.

Abstract Formatting Guidelines

• Abstracts should be written in English or French and be 250-300 words excluding the abstract title, authors and their designations and INCLUDES up to 3 references (Harvard style) where necessary and appropriate.
https://libguides.mq.edu.au/referencing/Harvard;

Abstracts must use the following outline (with the exception of case reports):

  • Background
  • Aims, objective or purpose
  • Methods
  • Results
  • Conclusion

For case reports ONLY use the following section headings:

  • Background
  • Case Summary
  • Conclusion

• Interested authors should send a one-page CV/ bio, with latest publications and contact details (email address and phone numbers);

• Submissions should indicate the theme that the abstract falls under. Please select the most appropriate topic category that fits into your submission from this list below and indicate the thematic number in your submission:

  1. Theme 1: Tuberculosis care in the era of COVID-19 pandemic including new approaches and novel techniques
  2. Theme 2: Pediatric Tuberculosis
  3. Theme 3: Drug Resistant Tuberculosis
  4. Theme 4: Policy in the area of Cross-Border TB
  5. Theme 5: Tuberculosis surveillance in cross border areas

• Please send your abstracts and other documents to this e-mail address:
This email address is being protected from spambots. You need JavaScript enabled to view it. with copy to This email address is being protected from spambots. You need JavaScript enabled to view it. and This email address is being protected from spambots. You need JavaScript enabled to view it.

Important Dates

Deadline for submission of abstracts: September 10th, 2021

Notification of acceptance of abstracts: September 20th, 2021

Conference Dates: October 25th-28th, 2021

Information note

 The decision of the reviewers and IGAD Secretariat on the acceptability of a submission is final.

 The reviewers and IGAD Secretariat reserve the right to accept or refuse an abstract and to choose a suitable session for the abstract.

 Declaration of Consent to Publication and Assignation of Copyright:
By submitting an abstract the authors collectively accept that the submitted abstract constitutes your consent to publication (e.g. conference website, programs, other promotions, etc.). The Abstract Submitter also grants the IGAD Secretariat a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content. The IGAD Secretariat reserve the right to remove from any publication or abstract which does not comply with the above. The corresponding author is responsible for informing the other authors about the status of the abstract.

Partners

This Conference is organized by IGAD and United States Agency for International Development/Kenya and East Africa (USAID/KEA) in cooperation with member states.

Please contact the conference secretariat if you have any queries regarding abstract submission. For any enquiries contact:

Hafsa Bashir Yussuf
IGAD SECRETRIAT
IGAD HEALTH AND SOCIAL DEVELOPMENT DIVISION
T: + 254 710 241 313 or +254 722 333 365
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 

 

 

22 December 2020 (DJIBOUTI, Djibouti) - The Intergovernmental Authority on Development (IGAD), in collaboration with the Delegation of the European Union to Djibouti and the United Nations Office for Project Services (UNOPS) yesterday held a Media Day to mark the handing over of medical supplies to the Government of Djibouti during an official ceremony at the Warehouse of the Ministry of Health of Djibouti located at PK12.  

Read more ...

August 12, 2020 (Obock, Djibouti): A team from IGAD- The Intergovernmental Authority for Development- made a visit on the 12th of August to the town of Obock-(Republic of Djibouti) to hand over a donation consisting of face masks and sanitary gel for the refugees in the Markazi camp as part of the efforts or actions to prevent the spread of COVID 19 virus. The donation was officially transferred to the authorities of the Prefecture of Obock and to officers of the National Office for Assistance to Refugees and Displaced persons (ONARS) in the presence of members of the refugee community.

This visit by the IGAD team was an opportunity to learn first-hand about the extremely precarious social conditions of the migrant populations in the Obock region.

The visit of the IGAD team to Obock was a continuation of   field visits undertaken at Holl-Holl refugee camp and Aour Aoussa Migrant center in the Ali Sabieh Region, in the southern part of the Republic of Djibouti, in the course of June and July 2020 by the Executive Secretary of IGAD His Excellency Dr. Workneh Gebeyehu. During these visits, the Executive Secretary of IGAD handed over similar donations of sanitary equipment to demonstrate the solidarity and IGAD's commitment to mitigate the impacts of the COVID 19 pandemic on vulnerable groups such as refugees and migrants.

While visiting Obock, the IGAD team IGAD witnessed various challenges and identified the humanitarian expectations and the needs of the vulnerable populations.

Obock Region, located in the northern part of the Republic of Djibouti, is a major migratory route and crossing point for thousands of migrants from IGAD Countries.

The humanitarian situation of migrant is particularly worrying, especially in the current context of the Covid 19 pandemic.

Finding durable solutions to the migrants and refugees remains an absolute priority.  And IGAD will continue to exert concerted efforts to ensure the effective implementation of regional strategy for COVID-19 response   and better coordination between the Member States will.

Dec. 11, 2019 (ADDIS ABABA, Ethiopia): The Director of Health and Social Development of the Intergovernmental Authority on Development (IGAD)-Ms Fathia A. Alwan, and the Health Director General of the Ministry of Health of Ethiopia-Dr. S. Tadesse, this morning inaugurated a cross border collaboration orientation meeting to establish inter-country referral mechanism among Member States.

 Participants to the meeting are:

  • Various actors from member states including National Tuberculosis managers, members of the national Country Coordination Mechanism (CCM) and members and District Health Offices at the border areas;
  • Sub recipient stakeholders such as the UNHCR country offices from the region, the Kenya Red Cross Society (KRCS) and the Administration for Repatriation and Returnees Affairs of Ethiopia (ARRA); and
  • Refugee camps operations.

The overall objective of the meeting is to strengthen collaboration strategies across border areas through revitalisation of already existing and established cross border platforms while improving linkages between refugee health settings and cross border areas thanks to the grant received from the Global Fund.

Strengthening regional coordination and collaboration for effective HIV, TB and Malaria service delivery in the cross-border areas and refuge settings is among the priority focus of the IGAD HIV, TB and malaria strategic plan 2018-2025’, according to the Director of the Heath and Social Development Division at IGAD.

The Global Fund grant has a component for cross border collaboration, and which is aimed ‘at facilitating continuum of care across the border areas and improving of health collaboration through revitalising the coordination mechanism and having functional referral mechanisms’, Ms Fathia A. Alwan also said in her opening remarks.

By the end of the cross border collaboration and orientation meeting, participants would have agreed on:

  • The role and responsibilities of a coordination committee;
  • The operation modalities for the cross border collaboration;
  • A country plan for rolling out the cross border health collaboration;
  • A joint plan (pairing) and milestones/deliverables in line with project work plan; and
  • A validated Referral Form.

The grant from the Global Fund is implemented by IGAD as the principal recipient and UNHCR, ARRA, and KRCS as sub recipients through already identified sub-sub recipients in 52 refugee camps located in Djibouti, Ethiopia, Kenya, South Sudan, Sudan and Uganda and cross border collaboration activities in all IGAD member countries.

 

Headlines

Latest IGAD Communiqué

COMMUNIQUÉ OF THE 38TH EXTRAORDINARY ASSEMBLY OF IGAD HEADS OF STATE AND GOVERNMENT COMMUNIQUÉ OF THE 38TH EXTRAORDINARY ASSEMBLY OF IGAD HEADS OF STATE AND GOVERNMENT 2020-12-21 - Here attached the COMMUNIQUÉ OF THE 38TH EXTRAORDINARY ASSEMBLY... More detail
COMMUNIQUE OF THE SPECIAL SESSION OF THE IGAD BUSINESS FORUM HELD VIRTUALLY ON 27TH AUGUST 2020 COMMUNIQUE OF THE SPECIAL SESSION OF THE IGAD BUSINESS FORUM HELD VIRTUALLY ON 27TH AUGUST 2020 2020-08-29 - His Excellency, Dr. Workneh Gebeyehu, Executive Secretary of... More detail